alanylglutamine has been researched along with Cirrhosis, Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, J; Li, L; Ma, H; Ying, H; Zhao, Y; Zheng, Y | 1 |
| Druml, W; Hübl, W; Lochs, H; Roth, E | 1 |
2 other study(ies) available for alanylglutamine and Cirrhosis, Liver
| Article | Year |
|---|---|
Alanyl-Glutamine Protects Mice against Methionine- and Choline-Deficient-Diet-Induced Steatohepatitis and Fibrosis by Modulating Oxidative Stress and Inflammation.
Topics: Alanine Transaminase; Animals; Anti-Inflammatory Agents; Antioxidants; Aspartate Aminotransferases; Choline; Diet; Dipeptides; Fatty Acids; Glutathione Peroxidase; Inflammation; Lactate Dehydrogenases; Lipids; Liver; Liver Cirrhosis; Methionine; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Racemethionine; Superoxide Dismutase | 2022 |
Importance of liver and kidney for the utilization of glutamine-containing dipeptides in man.
Topics: Adult; Amino Acids; Dipeptides; Female; Glutamine; Humans; Kidney; Kidney Failure, Chronic; Liver; Liver Cirrhosis; Male; Middle Aged; Reference Values | 1994 |